Literature DB >> 26550276

MDM2 T309G polymorphism and esophageal cancer risk: a meta-analysis.

Caipeng Lei1, Weiguo Zhang1, Junli Fan1, Bin Qiao1, Qiang Chen1, Qin Liu1, Chunling Zhao2.   

Abstract

Murine double minute 2 (MDM2) has suggested to play an important role in esophageal cancer. The association between MDM2 T309G polymorphism and esophageal cancer risk was inconclusive. To clarify the possible association, we conducted a meta-analysis. We searched in the PubMed, Embase, and Wanfang databases. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association. A total of 6 studies with 4909 cases and controls were included based on the search criteria. The MDM2 T309G polymorphism was associated with a significantly decreased risk of esophageal cancer (OR=0.88; 95% CI, 0.81-0.96; I(2)=22%). When stratified by type of race, a significantly decreased esophageal cancer risk were observed in Asians (OR=0.85; 95% CI, 0.78-0.93; I(2)=0%). In conclusion, this meta-analysis suggested that MDM2 T309G polymorphism was associated with a significantly decreased risk of esophageal cancer.

Entities:  

Keywords:  Esophageal cancer; MDM2; meta-analysis; polymorphism

Year:  2015        PMID: 26550276      PMCID: PMC4612961     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  13 in total

1.  Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high-incidence area.

Authors:  L D Wang; Q Zhou; C S Yang
Journal:  J Cell Biochem Suppl       Date:  1997

2.  TP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.

Authors:  Amit Man Joshi; Sanjeev Budhathoki; Keizo Ohnaka; Ryuichi Mibu; Masao Tanaka; Yoshihiro Kakeji; Yoshihiko Maehara; Takeshi Okamura; Koji Ikejiri; Kitaroh Futami; Takafumi Maekawa; Yohichi Yasunami
Journal:  Jpn J Clin Oncol       Date:  2010-11-04       Impact factor: 3.019

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma.

Authors:  Xingming Chen; Erich M Sturgis; Dapeng Lei; Kristina Dahlstrom; Qingyi Wei; Guojun Li
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

5.  MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner.

Authors:  Gareth L Bond; Kim M Hirshfield; Tomas Kirchhoff; Gabriella Alexe; Elisabeth E Bond; Harlan Robins; Frank Bartel; Helge Taubert; Peter Wuerl; William Hait; Deborah Toppmeyer; Kenneth Offit; Arnold J Levine
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

6.  The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.

Authors:  Yuan Hong; Xiaoping Miao; Xuemei Zhang; Fang Ding; Aiping Luo; Yongli Guo; Wen Tan; Zhihua Liu; Dongxin Lin
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

7.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

8.  Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.

Authors:  K Martin; D Trouche; C Hagemeier; T S Sørensen; N B La Thangue; T Kouzarides
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

9.  MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.

Authors:  Hiroshi Hirata; Yuji Hinoda; Nobuyuki Kikuno; Ken Kawamoto; Yutaka Suehiro; Yuichiro Tanaka; Rajvir Dahiya
Journal:  Clin Cancer Res       Date:  2007-07-15       Impact factor: 12.531

10.  p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma.

Authors:  G Liu; D W Cescon; R Zhai; W Zhou; M H Kulke; C Ma; W Xu; L Su; K Asomaning; R S Heist; J C Wain; T J Lynch; D C Christiani
Journal:  Dis Esophagus       Date:  2009-03-17       Impact factor: 3.429

View more
  2 in total

1.  P53 and Murine Double Mimute 2 (MDM2) Expression Changes and Significance in Different Types of Endometrial Lesions.

Authors:  Zhongyong Jiang; Wanqing Xu; Gang Dan; Yuan Liu; Jie Xiong
Journal:  Med Sci Monit       Date:  2016-12-07

2.  A case-control study on the SNP309T → G and 40-bp Del1518 of the MDM2 gene and a systematic review for MDM2 polymorphisms in the patients with breast cancer.

Authors:  Amin Jalilvand; Kheirollah Yari; Mozaffar Aznab; Zohreh Rahimi; Iman Salahshouri Far; Pantea Mohammadi
Journal:  J Clin Lab Anal       Date:  2020-09-20       Impact factor: 3.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.